Westpac Banking Corp’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-269
| Closed | -$50.9K | – | 518 |
|
|
2026
Q1 | $50.9K | Buy |
+269
| New | +$47K | ﹤0.01% | 472 |
|
|
2024
Q2 | – | Sell |
-3,018
| Closed | -$363K | – | 472 |
|
|
2024
Q1 | $363K | Buy |
+3,018
| New | +$370K | 0.03% | 286 |
|
|
2023
Q2 | – | Sell |
-4,873
| Closed | -$713K | – | 635 |
|
|
2023
Q1 | $713K | Hold |
4,873
| – | – | 0.01% | 703 |
|
|
2022
Q4 | $776K | Hold |
4,873
| – | – | 0.01% | 650 |
|
|
2022
Q3 | $650K | Hold |
4,873
| – | – | 0.01% | 682 |
|
|
2022
Q2 | $760K | Hold |
4,873
| – | – | 0.01% | 705 |
|
|
2022
Q1 | $759K | Hold |
4,873
| – | – | 0.01% | 730 |
|
|
2021
Q4 | $621K | Hold |
4,873
| – | – | 0.01% | 762 |
|
|
2021
Q3 | $635K | Hold |
4,873
| – | – | 0.01% | 781 |
|
|
2021
Q2 | $866K | Buy |
+4,873
| New | +$844K | 0.01% | 768 |
|
|
2021
Q1 | – | Sell |
-4,873
| Closed | -$804K | – | 812 |
|
|
2020
Q4 | $804K | Hold |
4,873
| – | – | 0.01% | 762 |
|
|
2020
Q3 | $695K | Hold |
4,873
| – | – | 0.01% | 744 |
|
|
2020
Q2 | $538K | Hold |
4,873
| – | – | 0.01% | 756 |
|
|
2020
Q1 | $486K | Hold |
4,873
| – | – | 0.01% | 724 |
|
|
2019
Q4 | $727K | Hold |
4,873
| – | – | 0.01% | 754 |
|
|
2019
Q3 | $624K | Buy |
+4,873
| New | +$653K | 0.01% | 743 |
|
|
2019
Q1 | – | Sell |
-3,283
| Closed | -$407K | – | 767 |
|
|
2018
Q4 | $407K | Buy |
+3,283
| New | +$487K | 0.01% | 743 |
|
|
2017
Q4 | – | Sell |
-3,283
| Closed | -$480K | – | 742 |
|
|
2017
Q3 | $480K | Sell |
3,283
-133
| -4% | -$20.1K | 0.01% | 695 |
|
|
2017
Q2 | $531K | Sell |
3,416
-2,624
| -43% | -$401K | 0.01% | 696 |
|
|
2017
Q1 | $877K | Sell |
6,040
-7,563
| -56% | -$985K | 0.01% | 673 |
|
|
2016
Q4 | $1.94M | Sell |
13,603
-6,566
| -33% | -$731K | 0.02% | 486 |
|
|
2016
Q3 | $2.45M | Buy |
20,169
+14,153
| +235% | +$1.91M | 0.03% | 432 |
|
|
2016
Q2 | $850K | Buy |
6,016
+1,590
| +36% | +$234K | 0.01% | 615 |
|
|
2016
Q1 | $578K | Buy |
4,426
+2,650
| +149% | +$330K | 0.01% | 648 |
|
|
2015
Q4 | $250K | Sell |
1,776
-1,715,901
| -100% | -$238M | ﹤0.01% | 797 |
|
|
2015
Q3 | $228M | Sell |
1,717,677
-137,898
| -7% | -$23.7M | 2.51% | 4 |
|
|
2015
Q2 | $327M | Buy |
1,855,575
+247,503
| +15% | +$44.4M | 3.2% | 2 |
|
|
2015
Q1 | $278M | Buy |
1,608,072
+152,985
| +11% | +$26.3M | 2.41% | 3 |
|
|
2014
Q4 | $238M | Buy |
1,455,087
+62,957
| +5% | +$10.4M | 2.27% | 6 |
|
|
2014
Q3 | $224M | Sell |
1,392,130
-143,729
| -9% | -$22.1M | 2.18% | 8 |
|
|
2014
Q2 | $226M | Buy |
1,535,859
+271,737
| +21% | +$37.7M | 2.18% | 5 |
|
|
2014
Q1 | $175M | Sell |
1,264,122
-124,002
| -9% | -$18.7M | 1.87% | 8 |
|
|
2013
Q4 | $176M | Sell |
1,388,124
-2,649,711
| -66% | -$274M | 2.01% | 4 |
|
|
2013
Q3 | $316M | Buy |
+4,037,835
| New | +$326M | 3.95% | 1 |
|
Other funds holding JAZZ
Westpac Banking Corp's JAZZ Position: Q2 2026 in Review
Westpac Banking Corp sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2026, closing a stake of 269 shares — an estimated $50.9K sold.
Westpac Banking Corp first reported a position in JAZZ in Q3 2013 and held it in 34 quarters. The position peaked at $327M in Q2 2015. 645 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Westpac Banking Corp reported no remaining Jazz Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Westpac Banking Corp sold 269 Jazz Pharmaceuticals shares in Q2 2026, an estimated $50.9K.
- Westpac Banking Corp first reported a position in Jazz Pharmaceuticals in Q3 2013 and held it in 34 quarters.
- Westpac Banking Corp's Jazz Pharmaceuticals position peaked at $327M in Q2 2015.
- 645 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Westpac Banking Corp's 13F filing for Q2 2026, filed 12 Aug 2026.